Loading...

Nexeon MedSystems Inc.

NXNN•PNK
HealthcareMedical - Devices
$0.00
$0.00(0.00%)

Nexeon MedSystems Inc. (NXNN) Stock Overview

Explore Nexeon MedSystems Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for NXNNStats details for NXNN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for NXNNAnalyst Recommendations details for NXNN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

CEO

Mr. William Rosellini J.D., M.B.A., M.S.

Employees

62

Headquarters

1910 Pacific Avenue, Dallas, TX

Founded

2017

Frequently Asked Questions